日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study

KEYNOTE-966研究中乙型肝炎病毒感染对帕博利珠单抗联合化疗治疗晚期胆道癌疗效和安全性的影响

Chan, Stephen L; Yau, Thomas; Kelley, Robin K; Finn, Richard S; Yoo, Changhoon; Furuse, Junji; Ren, Zhenggang; Klümpen, Heinz-Josef; Ozaka, Masato; Pelzer, Uwe; Arslan, Cagatay; Park, Joon Oh; Edeline, Julien; Valle, Juan W; Ueno, Makoto; Vogel, Arndt; Starkopf, Liis; Malhotra, Usha; Siegel, Abby B; Qin, Shukui

Advancements in intratumoral therapies for liver tumors

肝肿瘤瘤内治疗的进展

Raman, Steven S; Cutler, Neal R; Sramek, John J; Hecht, J Randolph; Finn, Richard S; Anand, Sidharth R; Chiang, Jason; Lu, David S

Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care

CDK4/6抑制剂在转移性乳腺癌中的比较疗效:利用目标试验模拟框架研究常规治疗中的总生存期

Brufsky, Adam M; Finn, Richard S; Metzger, Otto; Goncalves, Rodrigo; Huang-Bartlett, Cynthia; Sreenivasan, Sameet; Nur, Ula; Davies, Jessica; Grigorenko, Alex; Long, Gráinne H

Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients

细胞外囊泡数字评分检测法用于评估肝细胞癌患者的治疗反应

Zhao, Chen; Lee, Yi-Te; Melehy, Andrew; Kim, Minhyung; Yang, Jacqueline Ziqian; Zhang, Ceng; Kim, Jina; Zhang, Ryan Y; Lee, Junseok; Kim, Hyoyong; Ju, Yong; Tsai, Yuan-Jen; Zhou, Xianghong Jasmine; Han, Steven-Huy B; Sadeghi, Saeed; Finn, Richard S; Saab, Sammy; Lu, David S; Chiang, Jason; Park, Jae-Ho; Brennan, Todd V; Wisel, Steven A; Alsudaney, Manaf; Kuo, Alexander; Ayoub, Walid S; Kim, Hyunseok; Trivedi, Hirsh D; Wang, Yun; Vipani, Aarshi; Kim, Irene K; Todo, Tsuyoshi; Steggerda, Justin A; Voidonikolas, Georgios; Kosari, Kambiz; Nissen, Nicholas N; Saouaf, Rola; Singal, Amit G; Sim, Myung Shin; Elashoff, David A; You, Sungyong; Agopian, Vatche G; Yang, Ju Dong; Tseng, Hsian-Rong; Zhu, Yazhen

Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus Bevacizumab

一项多中心 II 期试验,评估瑞戈非尼二线治疗在接受阿特珠单抗联合贝伐珠单抗治疗后进展的不可切除肝细胞癌患者的疗效

Cheon, Jaekyung; Ryoo, Baek-Yeol; Chon, Hong Jae; Kim, Hyung-Don; Ryu, Min-Hee; Kim, Kyu-Pyo; Kang, Beodeul; Finn, Richard S; Chan, Stephen Lam; Yoo, Changhoon

Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study

瑞戈非尼治疗肝细胞癌的真实世界实践(REFINE):一项前瞻性观察研究

Kim, Yoon Jun; Merle, Philippe; Finn, Richard S; Kudo, Masatoshi; Klümpen, Heinz-Josef; Lim, Ho Yeong; Ikeda, Masafumi; Granito, Alessandro; Masi, Gianluca; Gerolami, René; Cho, Sung Bum; Hsu, Chih-Hung; Huang, Yi-Hsiang; Jeng, Long-Bin; Kim, Do Young; Lin, Shi-Ming; Pinter, Matthias; Shao, Guoliang; Kato, Naoya; Kurosaki, Masayuki; Numata, Kazushi; Kuo, Kung-Kai; Mao, Yilei; Lin, Yih-Jyh; Zhu, Kangshun; Twumasi-Ankrah, Philip; Khan, Javeed; Awan, Maria; Ozgurdal, Kirhan; Qin, Shukui

Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150

治疗深度和持续时间与不可切除肝细胞癌患者的生存率相关:IMbrave150 的探索性分析

Kudo, Masatoshi; Yamashita, Tatsuya; Finn, Richard S; Galle, Peter R; Ducreux, Michel; Cheng, Ann-Lii; Tsuchiya, Kaoru; Sakamoto, Naoya; Hige, Shuhei; Take, Ryosuke; Yamada, Kyoko; Nakagawa, Yuki; Takahashi, Hayato; Ikeda, Masafumi

Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌患者循环肿瘤DNA的临床可行性

Hwang, Sohyun; Shin, Dong Jun; Kang, Beodeul; Kang, Haeyoun; Lee, Sung Hwan; Kim, Jung Sun; Joung, Je-Gun; Jain, Suyog; Olsen, Steven; Becker, Lars; Finn, Richard S; Llovet, Josep M; Kim, Gwangil; Kim, Chan; Chon, Hong Jae

Targeting TIGIT to improve outcomes in advanced HCC

靶向TIGIT可改善晚期肝细胞癌的预后

Bejjani, Anthony C; Roayaie, Sasan; Finn, Richard S

Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies

晚期肝细胞癌二线治疗:帕博利珠单抗:KEYNOTE-240 和 KEYNOTE-394 III 期研究的荟萃分析

Finn, Richard S; Gu, Kangsheng; Chen, Xi; Merle, Philippe; Lee, Kyung-Hun; Bouattour, Mohamed; Cao, Peiguo; Wang, Wei; Cheng, Ann-Lii; Zhu, Liangjun; Lim, Ho Yeong; Kudo, Masatoshi; Pan, Yueyin; Chang, Ting-Tsung; Edeline, Julien; Li, Wei; Yang, Ping; Li, Chen; Li, Jianfeng; Siegel, Abby B; Qin, Shukui